http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102346184-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_279b4c171d4ef5996ccd96c093a55ddf |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2010-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d9c3db8a624401dc4945001fa59a06f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa0e09e3ba28c79e1301c36528accc5b |
| publicationDate | 2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102346184-B |
| titleOfInvention | Novel application of Spondin-2 (SPON2) |
| abstract | The invention discloses novel application of Spondin-2 (SPON2). The novel application is application of an antibody for the SPON2 in preparation of a kit for aided diagnosis of prostatic cancer. An experiment shows that: an enzyme coupled immune kit for detecting the SPON2 or an immunohistochemistry kit for detecting the SPON2 are used for diagnosing the prostatic cancer, so a diagnosis result is more precise and accurate; and the novel application is superior to the conventional prostatic specific antigen (PSA) diagnosis method. |
| priorityDate | 2010-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.